New study aims to sharpen brain tumor monitoring with PET imaging
NCT ID NCT07159607
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 100 adults with IDH-mutant gliomas (a type of brain tumor) to see if special PET scans can better detect tumor growth or treatment side effects compared to standard MRI. Researchers will collect PET images taken during routine care and compare them with patient outcomes like survival. The goal is to improve future guidelines for monitoring these tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could improve how doctors use PET scans to tell if a brain tumor is growing or just reacting to treatment, leading to better monitoring guidelines.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly help patients. Results may not change practice if the PET findings don't clearly link to outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDH-MUTANT GLIOMA (OLIGODENDROGLIOMA, ASTROCYTOMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LMU Hospital
RECRUITINGMunich, Bavaria, 81377, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Medical University of Vienna
RECRUITINGVienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••